Most lately, it's been identified that conolidine and the above mentioned derivatives act on the atypical chemokine receptor three (ACKR3. Expressed in comparable places as classical opioid receptors, it binds to the big selection of endogenous opioids. Contrary to most opioid receptors, this receptor acts like a scavenger and would not activate a